AbCellera Biologics, Inc. (ABCL)
4.565
+0.52
(+12.72%)
USD |
NASDAQ |
May 20, 16:00
4.57
0.00 (0.00%)
After-Hours: 07:47
AbCellera Biologics Research and Development Expense (TTM) : 191.00M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Standard BioTools, Inc. | 22.48M |
| Cytek Biosciences, Inc. | 36.35M |
| Tempus AI, Inc. | 343.92M |
| Agilent Technologies, Inc. | 454.00M |
| Inotiv, Inc. | -- |